Details for: BOSULIF
Company: PFIZER CANADA ULC
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02419149 | BOSULIF | BOSUTINIB (BOSUTINIB MONOHYDRATE) | 100 MG | TABLET | ORAL |
| 02419157 | BOSULIF | BOSUTINIB (BOSUTINIB MONOHYDRATE) | 500 MG | TABLET | ORAL |
Summary Reports
Summary Basis of Decision
Regulatory Decision Summary
Summary Safety Review - Bcr-Abl Tyrosine Kinase Inhibitors - Assessing the Potential Harm to the Fetus
Regulatory Decision Summary
Summary Safety Review - Bcr-Abl Tyrosine Kinase Inhibitors - Assessing the Potential Harm to the Fetus
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.